CV THERAPEUTICS INC (CVTX) has 9 open-market insider trades by 6 insiders since 2006. The most active filer is Lewis J. Stuart, SVP COMMERCIAL OPERATIONS.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Louis G. Lange | Chairman | — | 1 | $9.5M | 2009-04-09 |
| Daniel K. Spiegelman | CFOSVP | — | 1 | $2.8M | 2009-04-09 |
| Barbara J. McNeil | Dir | — | 2 | $221K | 2007-03-30 |
| Brent K. Blackburn | SVPDrug Discovery & Dev | — | 1 | $101K | 2009-04-02 |
| Lewis J. Stuart | SVP COMMERCIAL OPERATIONS | — | 3 | $92K | 2009-04-08 |
| Thomas L. Gutshall | Dir | — | 1 | $68K | 2009-04-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel K. Spiegelman | CFO & SVP | Sell | $2.8M | 2009-04-02 |
| Louis G. Lange | Chairman | Sell | $9.5M | 2009-04-02 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $14K | 2009-01-07 |
| Lewis J. Stuart | SVP COMMERCIAL OPERATIONS | Sell | $26K | 2008-11-20 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $21K | 2008-11-06 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell |
Companies that share insiders with CVTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $18K |
| 2008-10-14 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $15K | 2008-09-09 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $15K | 2008-08-13 |
| Lewis J. Stuart | SVP COMMERCIAL OPERATIONS | Sell | $41K | 2008-08-08 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $119K | 2008-07-31 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $10K | 2008-07-08 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $7K | 2008-06-17 |
| Tricia Borga Suvari | SVP & General Counsel & Sec | Sell | $26K | 2008-04-30 |
| Brent K. Blackburn | SVP & Drug Discovery & Dev | Sell | $119K | 2008-04-25 |
| Tricia Borga Suvari | SVP & General Counsel & Sec | Sell | $24K | 2008-03-31 |